Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price

This summer, emergency rooms are seeing a surge in people seeking treatment for tick bites—especially in areas like upstate New York, where outdoor activities are booming. A camp doctor shares firsthand observations of the spike, hinting at possible factors like warmer weather or rising tick populations. Experts are urging caution (and bug spray) for anyone spending time outside.

Editor’s Note: Tick bites aren’t just itchy annoyances—they can carry serious diseases like Lyme. If more people are ending up in the ER, it’s a red flag that either ticks are getting worse, awareness is lagging, or both. For hikers, parents, and pet owners, this is a heads-up to double-check for ticks and know the warning signs.

A new report highlights stark disparities in NHS waiting times, with gynaecology patients facing some of the longest delays in England. The data underscores systemic imbalances in how healthcare resources are allocated, leaving many women stuck in limbo for essential care.

Editor’s Note: This isn’t just about long waits—it’s about who’s being left behind. When gynaecology services are consistently overwhelmed, it signals a deeper issue in prioritising women’s health. For patients, prolonged delays can mean worsening conditions, added stress, and even life-altering consequences. The story matters because it forces us to ask why some medical needs keep getting deprioritised, and what it’ll take to fix it.

Doctors are sounding the alarm as gastrointestinal cancers—like colorectal, stomach, and pancreatic—are surging in adults under 50. The trend is clear, but the reasons behind it remain a mystery, leaving experts scrambling for answers.

Editor’s Note: This isn’t just a medical curiosity—it’s a worrying shift that could reshape early screening guidelines and lifestyle recommendations. If you’re in your 30s or 40s, this hits close to home, especially since no one’s entirely sure what’s driving the spike. It’s a reminder that cancer isn’t just an "older person’s problem" anymore.

A panel of experts advising the FDA is taking another look at the long-standing warnings about hormone replacement therapy (HRT) for menopause. The current labels highlight risks like breast cancer and heart disease, but newer research suggests the picture might be more nuanced—especially for younger women or those with severe symptoms. This could lead to updated guidelines that better reflect who might benefit versus who should avoid it.

Editor’s Note: Hormone therapy has been a hot-button issue for years—many women swore by it for relief from brutal menopause symptoms, while others avoided it over safety fears. If the FDA tweaks its stance, it could mean clearer, more personalized advice for millions navigating this stage of life. It’s not about declaring HRT "safe" or "dangerous" outright, but figuring out who it makes sense for. That’s progress.

Former President Trump claims Coca-Cola execs have promised to bring back real cane sugar as the sweetener in U.S. products—a nostalgic nod to the "Mexican Coke" fans love. But the company hasn’t confirmed the change yet, only hinting at upcoming "innovative offerings."

Editor’s Note: If true, this could be a big deal for soda purists who swear by cane sugar’s taste over high-fructose corn syrup. But until Coke confirms, it’s just political chatter with a side of fizzy speculation. Either way, it’s a reminder of how food choices get tangled up in cultural and economic debates.